The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Cyclin D1 in Cancer: A Molecular Connection for Cell Cycle Control, Adhesion and Invasion in Tumor and Stroma
Open accessAbstract
Cyclin D1, an important regulator of cell cycle, carries out a central role in the pathogenesis of cancer determining uncontrolled cellular proliferation. In normal cells, Cyclin D1 expression levels are strictly regulated, conversely, in cancer, its activity is intensified in various manners. Different studies demonstrate that CCDN1 gene is amplified in several tumor types considering it as a negative prognostic marker of this pathology. Cyclin D1 is known for its role in the nucleus, but recent clinical studies associate the amount located in the cytoplasmic membrane with tumor invasion and metastasis. Cyclin D1 has also other functions: it governs the expression of specific miRNAs and it plays a crucial role in the tumor-stroma interactions potentiating most of the cancer hallmarks. In the present review, we will summarize the current scientific evidences that highlight the involvement of Cyclin D1 in the pathogenesis of different types of cancer, best of all in breast cancer. We will also focus on recent insights regarding the Cyclin D1 as molecular bridge between cell cycle control, adhesion, invasion, and tumor/stroma/immune-system interplay in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
A microRNA polycistron as a potential human oncogene
He, L., Thomson, J. M., Hemann, M. T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,483
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,310
Finn, R. S., Crown, J. P., Lang, I., Boer, K., Bondarenko, I. M., Kulyk, S. O., Ettl, J., Patel, R., Pinter, T., Schmidt, M., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71159-3 · Cited by 1,900
Schulze, K., Imbeaud, S., Letouzé, E., Alexandrov, L. B., Calderaro, J., Rebouissou, S., Couchy, G., Meiller, C., Shinde, J., Soysouvanh, F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3252 · Cited by 1,803
Cyclin D as a therapeutic target in cancer
Musgrove, E. A., Caldon, C. E., Barraclough, J., Stone, A., & Sutherland, R. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3090 · Cited by 1,370
(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264
Lundberg, A. S., & Weinberg, R. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.753 · Cited by 1,067
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., & Schmidt, E. V. (1994) · Nature · doi:10.1038/369669a0 · Cited by 965
Specific protection against breast cancers by cyclin D1 ablation
Yu, Q., Geng, Y., & Sicinski, P. (2001) · Nature · doi:10.1038/35082500 · Cited by 934
Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells
Mishra, P. J., Mishra, P. J., Humeniuk, R., Medina, D. J., Alexe, G., Mesirov, J. P., Ganesan, S., Glod, J. W., & Banerjee, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0943 · Cited by 912
Diehl, J. A., Zindy, F., & Sherr, C. J. (1997) · Genes & Development · doi:10.1101/gad.11.8.957 · Cited by 746
Cyclin D1, cancer progression, and opportunities in cancer treatment
Qie, S., & Diehl, J. A. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1475-3 · Cited by 657
Anders, L., Ke, N., Hydbring, P., Choi, Y. J., Widlund, H. R., Chick, J. M., Zhai, H., Vidal, M., Gygi, S. P., Braun, P., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.001 · Cited by 543
Rho GTPase signaling complexes in cell migration and invasion
Lawson, C. D., & Ridley, A. J. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201612069 · Cited by 539
Bodrug, S. E., Warner, B. J., Bath, M. L., Lindeman, G. J., Harris, A. W., & Adams, J. M. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06488.x · Cited by 441
Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.
Lovec, H., Grzeschiczek, A., Kowalski, M. B., & Möröy, T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06655.x · Cited by 410
Agami, R., & Bernards, R. (2000) · Cell · doi:10.1016/s0092-8674(00)00010-6 · Cited by 390
A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation
Yu, Z., Wang, C., Wang, M., Li, Z., Casimiro, M. C., Liu, M., Wu, K., Whittle, J., Ju, X., Hyslop, T., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200801079 · Cited by 363
Lee, R. J., Albanese, C., Fu, M., D'Amico, M., Lin, B., Watanabe, G., Haines, G. K., Siegel, P. M., Hung, M.-C., Yarden, Y., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.672-683.2000 · Cited by 347
A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers
Jirawatnotai, S., Hu, Y., Michowski, W., Elias, J. E., Becks, L., Bienvenu, F., Zagozdzon, A., Goswami, T., Wang, Y. E., Clark, A. B., et al. (2011) · Nature · doi:10.1038/nature10155 · Cited by 333
CDK4/6 inhibition in breast cancer: current practice and future directions
Pernas, S., Tolaney, S. M., Winer, E. P., & Goel, S. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835918786451 · Cited by 316
Minireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?
Hickey, T. E., Robinson, J. L. L., Carroll, J. S., & Tilley, W. D. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1107 · Cited by 289
The double dealing of cyclin D1
Tchakarska, G., & Sola, B. (2020) · Cell Cycle · doi:10.1080/15384101.2019.1706903 · Cited by 278
Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen
Bienvenu, F., Jirawatnotai, S., Elias, J. E., Meyer, C. A., Mizeracka, K., Marson, A., Frampton, G. M., Cole, M. F., Odom, D. T., Odajima, J., et al. (2010) · Nature · doi:10.1038/nature08684 · Cited by 276
Fu, M., Rao, M., Bouras, T., Wang, C., Wu, K., Zhang, X., Li, Z., Yao, T.-P., & Pestell, R. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500403200 · Cited by 276
Genomic organization, chromosomal localization, and independent expression of human cyclin D genes
Inaba, T., Matsushime, H., Valentine, M., Roussel, M. F., Sherr, C. J., & Look, A. T. (1992) · Genomics · doi:10.1016/0888-7543(92)90126-d · Cited by 257
Wang, C., Li, Z., Lu, Y., Du, R., Katiyar, S., Yang, J., Fu, M., Leader, J. E., Quong, A., Novikoff, P. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603363103 · Cited by 208
Combined CDK4/6 and PI3Kα Inhibition Is Synergistic and Immunogenic in Triple-Negative Breast Cancer
Teo, Z. L., Versaci, S., Dushyanthen, S., Caramia, F., Savas, P., Mintoff, C. P., Zethoven, M., Virassamy, B., Luen, S. J., McArthur, G. A., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-2210 · Cited by 196
Knudsen, K. E., Cavenee, W. K., & Arden, K. C. (1999) · PubMed · Cited by 191
Reutens, A. T. (2001) · Molecular Endocrinology · doi:10.1210/me.15.5.797 · Cited by 189
Exosome‐encapsulated microRNAs as circulating biomarkers for breast cancer
Joyce, D. P., Kerin, M. J., & Dwyer, R. M. (2016) · International Journal of Cancer · doi:10.1002/ijc.30179 · Cited by 184
Cyclin D1 Determines Mitochondrial Function InVivo
Sakamaki, T., Casimiro, M. C., Ju, X., Quong, A. A., Katiyar, S., Liu, M., Jiao, X., Li, A., Zhang, X., Lu, Y., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02074-05 · Cited by 183
P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor
McMahon, C., Suthiphongchai, T., DiRenzo, J., & Ewen, M. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5382 · Cited by 178
Cyclin D1 Regulates Cellular Migration through the Inhibition of Thrombospondin 1 and ROCK Signaling
Li, Z., Wang, C., Jiao, X., Lu, Y., Fu, M., Quong, A. A., Dye, C., Yang, J., Dai, M., Ju, X., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02124-05 · Cited by 177
Michaloglou, C., Crafter, C., Siersbaek, R., Delpuech, O., Curwen, J. O., Carnevalli, L. S., Staniszewska, A. D., Polanska, U. M., Cheraghchi-Bashi, A., Lawson, M., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0537 · Cited by 177
Zhong, Z., Yeow, W.-S., Zou, C., Wassell, R., Wang, C., Pestell, R. G., Quong, J. N., & Quong, A. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-08-1108 · Cited by 166
Cyclin D1Governs Adhesion and Motility of Macrophages
Neumeister, P., Pixley, F. J., Xiong, Y., Xie, H., Wu, K., Ashton, A. W., Cammer, M., Chan, A. Y., Symons, M. H., Stanley, E. R., et al. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.02-07-0102 · Cited by 161
The Cyclin D1 Gene Is Transcriptionally Repressed by Caveolin-1
Hulit, J., Bash, T., Fu, M., Galbiati, F., Albanese, C., Sage, D., Schlegel, A., Zhurinsky, J., Shtutman, M. S., Ben‐Ze'ev, A., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000321200 · Cited by 153
Global trends and predictions in ovarian cancer mortality
Malvezzi, M., Carioli, G., Rodríguez, T., Negri, E., & Vecchia, C. L. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw306 · Cited by 149
Bali, A., O’Brien, P. M., Edwards, L. S., Sutherland, R. L., Hacker, N. F., & Henshall, S. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0751 · Cited by 148
Proangiogenic Contribution of Adiponectin toward Mammary Tumor Growth In vivo
Landskroner-Eiger, S., Qian, B., Muise, E. S., Nawrocki, A. R., Berger, J. P., Fine, E. J., Koba, W., Deng, Y., Pollard, J. W., & Scherer, P. E. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2649 · Cited by 145
Xia, B., Yang, S., Liu, T., & Lou, G. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0322-4 · Cited by 142
Bockmeyer, C. L., Christgen, M., Müller, M., Fischer, S., Ahrens, P. R., Länger, F. P., Kreipe, H. H., & Lehmann, U. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1303-3 · Cited by 133
Breast cancer: from estrogen to androgen receptor
Andò, S., Amicis, F. D., Rago, V., Carpino, A., Maggiolini, M., Panno, M., & Lanzino, M. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00105-3 · Cited by 130
Cytoplasmic cyclin D1 regulates cell invasion and metastasis through the phosphorylation of paxillin
Fusté, N. P., Fernández-Hernández, R., Cemeli, T., Mirantes, C., Pedraza, N., Rafel, M., Torres‐Rosell, J., Colomina, N., Ferrezuelo, F., Dolcet, X., et al. (2016) · Nature Communications · doi:10.1038/ncomms11581 · Cited by 128
Cyclin D1 Functions in Cell Migration
Li, Z., Wang, C., Prendergast, G. C., & Pestell, R. G. (2006) · Cell Cycle · doi:10.4161/cc.5.21.3428 · Cited by 121
Hepatocellular carcinoma–related cyclin D1 is selectively regulated by autophagy degradation system
Wu, S., Lan, S., Wu, S., Chiu, Y., Lin, X., Su, I., Tsai, T., Yen, C., Lu, T., Liang, F., et al. (2018) · Hepatology · doi:10.1002/hep.29781 · Cited by 113
Bièche, I., Olivi, M., Noguès, C., Vidaud, M., & Lidereau, R. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600109 · Cited by 112
Chen, J., Bai, M., Ning, C., et al. (2015) · Oncogene · doi:10.1038/onc.2015.316 · Cited by 105
Cyclin D1 Antagonizes BRCA1 Repression of Estrogen Receptor α Activity
Wang, C., Fan, S., Li, Z., Fu, M., Rao, M., Ma, Y., Lisanti, M. P., Albanese, C., Katzenellenbogen, B. S., Kushner, P. J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0486 · Cited by 103
Aquila, S., Santoro, M., Caputo, A., Panno, M. L., Pezzi, V., & Amicis, F. D. (2020) · Cells · doi:10.3390/cells9071725 · Cited by 103
Cyclin D1 Is a Ligand-independent Co-repressor for Thyroid Hormone Receptors
Lin, H., Zhao, L., & Cheng, S.-Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203380200 · Cited by 101
Role of Cyclin D1 as a Mediator of c-Met– and β-Catenin–Induced Hepatocarcinogenesis
Patil, M. A., Lee, S. A., Macias, E., Lam, E. T., Xu, C., Jones, K. D., Ho, C., Rodríguez‐Puebla, M. L., & Chen, X. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2514 · Cited by 100
Lanzino, M., Sisci, D., Morelli, C., Garofalo, C., Catalano, S., Casaburi, I., Capparelli, C., Giordano, C., Giordano, F., Maggiolini, M., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq278 · Cited by 99
Regulation of the Functional Interaction between Cyclin D1 and the Estrogen Receptor
Lamb, J., Ladha, M. H., McMahon, C. M., Sutherland, R. L., & Ewen, M. E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8667-8675.2000 · Cited by 91
Lanzino, M., Amicis, F. D., McPhaul, M. J., Marsico, S., Panno, M. L., & Andò, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413576200 · Cited by 89
Lundgren, K., Brown, M., Pineda, S., Cuzick, J. M., Salter, J., Zabaglo, L. A., Howell, A., Dowsett, M., Landberg, G., & the TransATAC investigators (2012) · Breast Cancer Research · doi:10.1186/bcr3161 · Cited by 86
Chen, Y., Huang, Y., Gao, X., Li, Y., Lin, J., Chen, L., Chang, L., Chen, G., Guan, Y., Pan, L. K., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01620 · Cited by 84
Xia, W. G., Lo, C. M., Poon, R. Y. C., Cheung, T. T., Chan, A. C. Y., Chen, L., Yang, S., Tsao, G. S., & Wang, X. Q. (2017) · Oncotarget · doi:10.18632/oncotarget.16402 · Cited by 73
Cyclin D1 induction of Dicer governs microRNA processing and expression in breast cancer
Yu, Z., Wang, L., Wang, C., Ju, X., Wang, M., Chen, K., Loro, E., Li, Z., Zhang, Y., Wu, K., et al. (2013) · Nature Communications · doi:10.1038/ncomms3812 · Cited by 70
Tissue-Specific Consequences of Cyclin D1 Overexpression in Prostate Cancer Progression
He, Y., Franco, O. E., Jiang, M., Williams, K., Love, H. D., Coleman, I. M., Nelson, P. S., & Hayward, S. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0418 · Cited by 69
Estrogen receptor‐α drives adiponectin effects on cyclin D1 expression in breast cancer cells
Mauro, L., PELLEGRINO, M. A., Giordano, F., Ricchio, E., Rizza, P., Amicis, F. D., Catalano, S., Bonofiglio, D., Panno, M. L., & Andò, S. (2015) · The FASEB Journal · doi:10.1096/fj.14-262808 · Cited by 68
Cyclin D1 Restrains Oncogene-Induced Autophagy by Regulating the AMPK–LKB1 Signaling Axis
Casimiro, M. C., Sante, G. D., Rocco, A. D., Loro, E., Pupo, C., Pestell, T. G., Bisetto, S., Velasco-Velázquez, M. A., Jiao, X., Li, Z., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-0425 · Cited by 67
Zelivianski, S., Cooley, A. E., Kall, R., & Jeruss, J. S. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0537 · Cited by 65
Prx I Suppresses K-ras-Driven Lung Tumorigenesis by Opposing Redox-Sensitive ERK/Cyclin D1 Pathway
Park, Y., Kim, S., Lee, B.-K., Kim, H.-S., Song, I.-S., Shin, H.-J., Han, Y., Chang, K.-T., Kim, J., Lee, D., et al. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4421 · Cited by 54
Characterization of cytoplasmic cyclin D1 as a marker of invasiveness in cancer
Fusté, N. P., Castelblanco, E., Felip, I., Santacana, M., Fernández-Hernández, R., Gatius, S., Pedraza, N., Pallarés, J., Cemeli, T., Valls, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8876 · Cited by 52
Cytoplasmic cyclin D1 controls the migration and invasiveness of mantle lymphoma cells
Body, S., Esteve‐Arenys, A., Miloudi, H., Recasens-Zorzo, C., Tchakarska, G., Moros, A., Bustany, S., Vidal‐Crespo, A., Rodríguez, V., Lavigne, R., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14222-1 · Cited by 50
Orr, S. J., Gaymes, T. J., Ładoń, D., Chronis, C., Czepulkowski, B. H., Wang, R., Mufti, G. J., Marcotte, E. M., & Thomas, N. S. B. (2010) · Oncogene · doi:10.1038/onc.2010.138 · Cited by 48
Aberrant Expression of Cyclin D1 in Cancer
Inoue, K., & Fry, E. A. (2015) · Signal Transduction Insights · doi:10.4137/sti.s30306 · Cited by 46
Meng, H., Tian, L., Zhou, J., Li, Z., Jiao, X., Li, W. W., Plomann, M., Xu, Z., Lisanti, M. P., Wang, C., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.1.14243 · Cited by 46
Cyclin D1 Is a Selective Modifier of Androgen-dependent Signaling and Androgen Receptor Function
Comstock, C. E. S., Augello, M. A., Schiewer, M. J., Karch, J. M., Burd, C. J., Ertel, A., Knudsen, E. S., Jessen, W. J., Aronow, B. J., & Knudsen, K. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.170720 · Cited by 46
Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer
Wenze, S., Liping, S., Ai, T., Yingbing, Z., Ying, G., & Cui, J. (2013) · Journal of Biomedical Research · doi:10.7555/jbr.27.20130004 · Cited by 46
Cyclin D1 and cdk4 mediate development of neurologically destructive oligodendroglioma
Ciznadija, D., Liu, Y., Pyonteck, S. M., Holland, E. C., & Koff, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1031 · Cited by 44
Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth
Pestell, T. G., Jiao, X., Kumar, M., Peck, A. R., di Prisco, M., Deng, S., Li, Z., Ertel, A., Casimiro, M. C., Ju, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19953 · Cited by 44
Cyclin D1 overexpression induces global transcriptional downregulation in lymphoid neoplasms
Alberó, R., Enjuanes, A., Demajo, S., Castellano, G., Pinyol, M., García, N., Capdevila, C., Clot, G., Suárez-Cisneros, H., Shimada, M., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96520 · Cited by 44
Chien, H., Cheng, S., Liao, C., Wang, H., & Huang, S. (2019) · Cancers · doi:10.3390/cancers11060760 · Cited by 41
Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer
de Beça, F. F., Pereira, M., Cameselle‐Teijeiro, J., Martins, D. F., & Schmitt, F. C. (2015) · BMC Cancer · doi:10.1186/s12885-015-1266-1 · Cited by 36
Cyclin D1-mediated microRNA expression signature predicts breast cancer outcome
Wang, G., Gormley, M., Qiao, J., Zhao, Q., Wang, M., Sante, G. D., Deng, S., Lin, D., Pestell, T. G., Ju, X., et al. (2018) · Theranostics · doi:10.7150/thno.23877 · Cited by 36
Alhaja, E., Adán, J., Pagan, R., Mitjans, F., Cascalló, M., Rodríguez, M., Noé, V., Ciudad, C. J., Mazo, A., Vilaró, S., et al. (2004) · Angiogenesis · doi:10.1007/s10456-005-0368-9 · Cited by 35
Kamarajugadda, S., Becker, J. R., Hanse, E. A., Mashek, D. G., Mashek, M. T., Hendrickson, A. M., Mullany, L. K., & Albrecht, J. H. (2016) · Oncotarget · doi:10.18632/oncotarget.10274 · Cited by 33
Zhong, Q., Hu, Z., Li, Q., Yi, T., Li, J., & Yang, H. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.10.027 · Cited by 32
Paxillin phosphorylation at serine 273 and its effects on Rac, Rho and adhesion dynamics
Tang, K., Boudreau, C. G., Brown, C. M., & Khadra, A. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006303 · Cited by 31
Cytoplasmic cyclin D1 regulates glioblastoma dissemination
Cemeli, T., Guasch‐Vallés, M., Nàger, M., Felip, I., Cambray, S., Santacana, M., Gatius, S., Pedraza, N., Dolcet, X., Ferrezuelo, F., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5277 · Cited by 31
Cyclin D1 promotes secretion of pro-oncogenic immuno-miRNAs and piRNAs
Lü, J., Zhao, Q., Ding, X., Guo, Y., Li, Y., Xu, Z., Li, S., Wang, Z., Shen, L., Chen, H.-W., et al. (2020) · Clinical Science · doi:10.1042/cs20191318 · Cited by 29
The membrane-associated form of cyclin D1 enhances cellular invasion
Chen, K., Jiao, X., Ashton, A. W., Rocco, A. D., Pestell, T. G., Sun, Y., Zhao, J., Casimiro, M. C., Li, Z., Lisanti, M. P., et al. (2020) · Oncogenesis · doi:10.1038/s41389-020-00266-y · Cited by 25
Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma
Liu, H., Fang, Y., Wang, J.-W., Yuan, X., Fan, Y., Gao, S., Han, L., & Wang, K. (2020) · Medicine · doi:10.1097/md.0000000000020326 · Cited by 24
Montalto, F. I., Giordano, F., Chiodo, C., Marsico, S., Mauro, L., Sisci, D., Aquila, S., Lanzino, M., Panno, M. L., Andò, S., et al. (2019) · Cancers · doi:10.3390/cancers11081201 · Cited by 22
Self-citationAmicis, F. D., Chiodo, C., Morelli, C., Casaburi, I., Marsico, S., Bruno, R., Sisci, D., Andò, S., & Lanzino, M. (2019) · BMC Cancer · doi:10.1186/s12885-019-6262-4 · Cited by 21
Dragoj, M., Milosevic, Z. C., Banković, J., Dinić, J., Pešić, M., Tanić, N., & Stanković, T. (2015) · Tumor Biology · doi:10.1007/s13277-015-3620-y · Cited by 19
Bosone, I., Cavalla, P., Chiado'-Piat, L., Vito, N. D., & Schiffer, D. (2001) · Neuropathology · doi:10.1046/j.1440-1789.2001.00389.x · Cited by 17
Li, J., Yin, L., Su, K., ZHANG, G.-F., & Wang, J. (2014) · Oncology Letters · doi:10.3892/ol.2014.2350 · Cited by 14
GUO, L., Liu, S., Jakulin, A., Yilamu, D., Wang, B., & Yan, J. (2015) · PubMed · Cited by 12
Cited by
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS- Mutant Pancreatic Cancer
Goodwin, C. M., Waters, A. M., Klomp, J. E., Javaid, S., Bryant, K. L., Stalnecker, C. A., Drizyte-Miller, K., Papke, B., Yang, R., Amparo, A. M., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-0391 · Cited by 168
Chronotype and Cancer: Emerging Relation Between Chrononutrition and Oncology from Human Studies
Godos, J., Currenti, W., Ferri, R., Lanza, G., Caraci, F., Frias-Toral, E., Guglielmetti, M., Ferraris, C., Lipari, V., Carvajal Altamiranda, S., et al. (2025) · Nutrients · doi:10.3390/nu17030529 · Cited by 22
Targeting PP2A in cancer: an underrated option
Sarais, F., Krempien, F., Koehn, C., Brewing, L., Classen, C. F., Walter, M., & Shokraie, O. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03560-y · Cited by 8
Metadata
- Authors
- Montalto, F. I., & De Amicis, F.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-12-09
- Volume
- 9
- Issue
- 12
- Pages
- 2648
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W3112754852
- Cited by
- 496
- References
- 93
- FWCI
- 16.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.